Skip to content

AI Agent Eval Harness

Most GenAI pilots never show measurable P&L impact - they stall on four things: data readiness, risk and compliance, cost, and value. This reference implementation shows what buying those four down looks like, with the evidence to prove it.

This is the public reference for a measurement-first approach to GenAI in regulated industries: a conversational health agent for medication adherence whose every clinical assertion must cite a verified knowledge-base card - or the agent refuses - paired with a CI-gated evaluation harness that proves it.

For a one-page orientation aimed at decision-makers, start with the executive summary.

The four failure modes, each with an answer

Section titled “The four failure modes, each with an answer”

Roughly 70-95% of GenAI pilots stall before measurable impact, and four causes do most of the damage. Each one has a concrete artifact here:

The work runs as two sprints: Discovery - is this the right opportunity, is the data ready, what is the value and the risk - and PoC-to-Production - a measured, safe, production-shaped system with the evidence to ship it.